PROCEPT BioRobotics
  • CAREERS
  • VISIT OUR PATIENT SITE
  • Aquablation Therapy
  • AquaBeam Robotic System
  • Clinical Data
  • Company
    • Careers
    • Resources
      • Reimbursement
      • Aquablation FAQs
    • Contact Us
    • Request Information
  • Investors
    • News & Events
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Investor Resources
Select Page

PROCEPT BioRobotics Appoints Elisabeth Sandoval to Board of Directors

by Laurie Vertuccio | Oct 26, 2021

PROCEPT BioRobotics Corp. to Report Third Quarter 2021 Financial Results on November 4, 2021

by Laurie Vertuccio | Oct 21, 2021

PROCEPT BioRobotics Corporation Announces Cigna Adds Aquablation Therapy to its Coverage Policy

by Laurie Vertuccio | Sep 28, 2021

PROCEPT BioRobotics Corporation Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

by Laurie Vertuccio | Sep 21, 2021

PROCEPT BioRobotics Corporation Announces Pricing of Upsized Initial Public Offering

by Laurie Vertuccio | Sep 14, 2021

« Older Entries
PROCEPT symbol

900 Island Drive
Redwood City, CA 94605
+1 (650) 232-7200
info@PROCEPT-BioRobotics.com

Social

  • Facebook
  • twitter
  • linkedin
  • AQUABLATION THERAPY
  • AquaBeam ROBOTIC SYSTEM
  • RESOURCES
  • COMPANY
  • INVESTORS

Copyright 2020 PROCEPT BioRobotics Corporation. All Rights Reserved.
Safety InformationPatentsPrivacy PolicyCookie PolicyTerms Of UseTrademark GuidelinesCA Compliance
AquaBeam, AQUABLATION, and PROCEPT BIOROBOTICS are registered trademarks of PROCEPT BioRobotics. ML0141.P